Mortality associated with cardiovascular drugs in patients with chronic obstructive pulmonary disease and right-sided heart failure – A danish nationwide registry-based study
- 1 May 2019
- journal article
- research article
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 63, 56-61
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Effects of Cardiovascular Drugs on Mortality in Severe Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2013
- Anticoagulation therapy in patients with chronic obstructive pulmonary disease in the acute exacerbation stageExperimental and Therapeutic Medicine, 2013
- Benefits of blockers in patients with heart failure and reduced ejection fraction: network meta-analysisBMJ, 2013
- Epidemiology of chronic obstructive pulmonary disease: a literature reviewInternational Journal of Chronic Obstructive Pulmonary Disease, 2012
- The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of PatientsBMC Medical Research Methodology, 2011
- Effect of blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort studyBMJ, 2011
- β-Blockers May Reduce Mortality and Risk of Exacerbations in Patients With Chronic Obstructive Pulmonary DiseaseArchives of internal medicine (1960), 2010
- Impact of statins and ACE inhibitors on mortality after COPD exacerbationsRespiratory Research, 2009
- Constructing Inverse Probability Weights for Marginal Structural ModelsAmerican Journal of Epidemiology, 2008
- Reduction of Morbidity and Mortality by Statins, Angiotensin-Converting Enzyme Inhibitors, and Angiotensin Receptor Blockers in Patients With Chronic Obstructive Pulmonary DiseaseJACC, 2006